Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Weitere Synonyme anzeigen
Wählen Sie die gewünschte Spezies
Of two Jak2 paralogues present in zebrafish, Jak2a but not Jak2b is involved in the intracellular transmission of the Ifn-gamma (zeige IFNG Proteine) signal.
The prevalence of CALR (zeige CALR Proteine) mutation in JAK2V617F-negative essential thrombocythemia in this study is 35.7%. HRM is an effective method of detecting CALR (zeige CALR Proteine) mutation and is a more advantageous method of screening for CALR (zeige CALR Proteine) mutation.
Comprehensive genomic characterization identified distinct genetic subgroups and provided a classification of myeloproliferative neoplasms on the basis of causal biologic mechanisms. Mutations in JAK2, CALR (zeige CALR Proteine), or MPL (zeige MPL Proteine) being the sole abnormality in 45% of the patients.
Findings outlined in the current study demonstrated that the inhibition of P16 decreased the growth and metastasis potential of BC cells by inhibiting IL-6 (zeige IL6 Proteine)/JAK2/STAT3 (zeige STAT3 Proteine) signaling.
MPL (zeige MPL Proteine)-mutated and CALR (zeige CALR Proteine)-mutated essential thrombocythaemia share clinical and histological characteristics, with both genotypes showing higher platelet counts and a marked megakaryocytic proliferation in comparison with JAK2V617F-mutated ET.
results herein provide clues to understand the mechanism JAK2 V625F mutation caused myeloproliferative neoplasms and give information for the development of JAK2 mutation specific inhibitors.
A small drug acting as a JAK1 (zeige JAK1 Proteine)/2 inhibitor may also counteract the repressing effects of IL-6 (zeige IL6 Proteine).
The JAK2 V617F mutation and thrombocytopenia.
PBX1 (zeige PBX1 Proteine) plays an oncogenic role in clear cell renal carcinoma via JAK2/STAT3 (zeige STAT3 Proteine) pathway
Our study shows that JAK2V617F leads to abnormal expression of numerous proteins at the membrane of circulating PV red blood cells, with overexpression of CALR (zeige CALR Proteine) and persistence of CANX (zeige CANX Proteine)
In 94.9% of PV, 85.5% ET and 85.2% PMF (zeige PRB1 Proteine), authors found mutations in JAK2, MPL (zeige MPL Proteine) or CALR (zeige CALR Proteine). 74.9% carried JAK2V617F, 12.3% CALR (zeige CALR Proteine) mutations, 2.1% MPL (zeige MPL Proteine) mutations and 10.7% were triple negative.
Janus kinase 2 protein (JAK2) and beta-catenin (zeige CTNNB1 Proteine) were found to interact with cadherin-22 (Cdh22 (zeige CDH22 Proteine)) and involved in CDH22 (zeige CDH22 Proteine) signaling in female germ line stem cells (FGSCs).
results suggest that IL-6 (zeige IL6 Proteine) gene requires up-regulation of phospho-JAK2/STAT3 (zeige STAT3 Proteine), PACAP (zeige ADCYAP1 Proteine), and PAC1R (zeige ADCYAP1R1 Proteine) and down-regulation of the TNF-alpha (zeige TNF Proteine) gene to modulate its anticonvulsive/neuroprotective potential
While expression of mutant Jak2 was necessary for leukemia induction, neither its continued expression nor enzymatic activity was required to maintain leukemia survival and rapid proliferation
High JAK2 expression is associated with graft-versus-host disease.
Results demonstrate that JAK2 deficiency delays tumor formation in GH-transgenic mice, which is linked to insignificant oncogenic STAT3 (zeige STAT3 Proteine) signaling and reduced reactive oxygen species-induced oxidative damage.
Reg3g (zeige REG3g Proteine) acts as an immunosuppressive promoter by activating the JAK2/STAT3 (zeige STAT3 Proteine) signaling pathway in dendritic cells and triggering the generation of an immunosuppressive tumor microenvironment.
High JAK2 expression is associated with skeletal muscle wasting in cancer cachexia.
Data (including data from studies in knockout mice) suggest that various tissues utilize Jak2 signaling to regulate insulin (zeige INS Proteine), glucose, and lipid metabolism; adipocyte Jak2 appears to regulate hepatic insulin (zeige INS Proteine) resistance in mechanism independent of adiposity (obesity), liver lipid content (non-alcoholic fatty liver disease), and hepatic insulin (zeige INS Proteine) signaling.
Advanced glycation end products induce apoptosis and inflammation in mouse podocytes through CXCL9 (zeige CXCL9 Proteine)-mediated JAK2/STAT3 (zeige STAT3 Proteine) pathway activation.
Cilostazol protects MIR (zeige MLXIP Proteine) injury by activating a PPARgamma (zeige PPARG Proteine)/JAK2/STAT3 (zeige STAT3 Proteine) pathway.
nitration of JAK2 may act as an inhibitory counterpart to phosphorylation activation, reflecting a very localized break on the progression of GH signal transduction processes spanning JAK (zeige JAK3 Proteine)-STAT (zeige STAT1 Proteine)-AKT (zeige AKT1 Proteine) interactions
Janus kinase 2 (JAK2) gene polymorphism is a potential marker for milk production traits in cattle
Results indicate that SNPs in STAT5A (zeige STAT5A Proteine) and JAK2 genes were associated with somatic cell count and score in milk and cytokines but none of the SNP was associated with milk production traits suggesting an important role in immunity.
Methionine promoted casein synthesis, and this may be mediated by enhanced intracellular substrate availability and by activating JAK2-STAT5 (zeige STAT5A Proteine) and mTOR (zeige FRAP1 Proteine) signaling pathways.
SNPs in JAK2 and STAT5B (zeige STAT5B Proteine) are associated with mastitis susceptibility in Chinese Holstein cattle
Localized changes in the state of nitration of regulatory phosphorylation domains of JAK2 in caveoLAE during inflammation suggest a unique mechanism through which discrete signal transduction switching might occur in the liver
This gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon. Mice that do not express an active protein for this gene exhibit embryonic lethality associated with the absence of definitive erythropoiesis.
, PTK JAK2b
, protein tyrosine kinase JAK2b
, tyrosine-protein kinase JAK2
, Janus kinase 2 (a protein tyrosine kinase)
, tyrosine kinase